Drug Revolving Fund

Safe and effective delivery of preventive and therapeutic health services requires reliable and sustainable supply of pharmaceuticals and other medical commodities. High demand, limited funds and inefficient procurement and distribution processes can lead to frequent shortages in low income areas. There may also be the problem of the presence of fake, substandard or expired drugs.

One method for financing drug supplies is the establishment of Drug Revolving Funds (DRFs) in which, after an initial capital investment, supplies are replenished with monies collected from the sale of the drugs. An effective DRF ensures continuous availability, accessibility and affordability of quality drugs through a sustainable mechanism.

The Oloibiri Health Programme aims to set up a DRF to address the challenge of frequent stock outs of medicines and other supplies in project hospitals. The aim is to make essential drugs affordable to all who need them within the health facilities and communities in Ogbia LGA. 

A detailed assessment of the current management and availability of pharmaceuticals within the health facilities of Ogbia LGA has been conducted. It revealed that there are many challenges, including low levels of staffing, low staff morale, very poor quality drug storage and dispensing facilities, poor drug management protocols and a lack of essential drugs. All project facilities in Ogbia LGA experienced stock-out of drugs and other medical commodities in the month preceding the assessment.

After considering different options, programme stakeholders agreed that Oloibiri Health Programme will support establishment and operation of a sustainable DRF scheme in Ogbia LGA supported by a stand-alone Ogbia LGA Medical Store independently managed by a pharmacist assigned by the Hospital Management Board. Ogbia LGA Medical Store will serve as an assured source of drugs and medical supplies for project hospitals in Ogbia LGA. It will be a model medical store for Bayelsa state and will be integrated with the state’s drug mart which is being developed as part of state-wide efforts for improvement of the drug and medical supplies system.   

Oloibiri Health Programme

The Oloibiri Health Programme (OHP) is a three-year public health initiative, sponsored by Shell, to improve health and health care delivery for the communities of the Ogbia Local Government Area (LGA) in Oloibiri field, Nigeria. This Public Private People Partnership is championed by Shell as part of Nigeria’s centenary celebrations and is named after Oloibiri community where oil was first discovered in commercial quantities in Nigeria.

  • Hon Commissioner of Health, Prof Ebitimitula Etebu, Addressing the Bayelsa State Essential Drug List Review Committee during their Inauguration Ceremony
  • Prof Etebu (Hon Commissioner of Health), Dr Omietimi (Permanent Secretary), Dr Dinyain (Director of Medical Services) and Dr Wakinte (Director of Public Health) during the EDL Review Committee Inauguration
  • Pharm Alek Okunbriowei (Director of Pharmaceutical Services) Addressing the EDL Review Committee
  • Cross-section of the Bayelsa State Essential Drug List Review Committee Members
  • Inauguration of the Bayelsa State Essential Drug List Review Committee Members
  • Members of State Essential Drug List Review Committe Reviewing the List.
  • Members of State Essential Drug List Review Committe Reviewing the List
  • 2nd Meeting of the State Essential Drug List Review Committe
  • Director of Medical Services, Dr Amatare Dinyain and Other Committee Members Reviewing the Essential Medicine List